Aarey Drugs & Pharmaceuticals Ltd. | Small-cap | Healthcare
₹64.75
4.10%
| Aarey Drugs Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 4.7B
Gross Profit 118.8M 2.51%
Operating Income 3.1M 0.06%
Net Income 40.2M 0.85%
EPS (Diluted) ₹1.43

Balance Sheet Metrics

Total Assets 2.4B
Total Liabilities 997.9M
Shareholders Equity 1.4B
Debt to Equity 0.72

Cash Flow Metrics

Operating Cash Flow 843.5M
Free Cash Flow 44.5M

Revenue & Profitability Trend

Aarey Drugs Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 4.7B 4.0B 4.1B 4.9B 3.5B
Cost of Goods Sold 4.6B 3.8B 4.0B 4.7B 3.4B
Gross Profit 118.8M 132.0M 90.1M 195.5M 101.0M
Operating Expenses 88.3M 74.3M 40.8M 64.2M 43.9M
Operating Income 3.1M 28.2M 20.0M 94.9M 37.2M
Pre-tax Income 61.0M 53.4M 60.1M 100.4M 83.0M
Income Tax 20.8M 6.6M 22.4M 34.8M 17.9M
Net Income 40.2M 46.8M 37.7M 65.5M 65.1M
EPS (Diluted) ₹1.43 ₹1.84 ₹1.49 ₹2.72 ₹2.79

Income Statement Trend

Aarey Drugs Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 2.1B 2.8B 2.7B 2.2B 2.2B
Non-Current Assets 249.8M 207.1M 207.2M 263.5M 146.6M
Total Assets 2.4B 3.0B 2.9B 2.5B 2.3B
Liabilities
Current Liabilities 968.8M 1.7B 1.7B 1.3B 1.3B
Non-Current Liabilities 29.1M 39.9M 57.8M 48.0M 33.7M
Total Liabilities 997.9M 1.7B 1.7B 1.3B 1.3B
Equity
Total Shareholders Equity 1.4B 1.3B 1.2B 1.1B 988.6M

Balance Sheet Composition

Aarey Drugs Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 61.0M 53.4M 60.1M 100.3M 83.0M
Operating Cash Flow 843.5M -33.7M -182.9M 10.2M -271.8M
Investing Activities
Capital Expenditures -52.0M -7.2M -10.4M -22.0M -28.8M
Investing Cash Flow -59.4M -17.0M 4.4M -32.1M -28.8M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 1.8M 99.6M 42.2M 42.5M 0
Free Cash Flow 44.5M -37.2M -23.3M -17.0M 26.0M

Cash Flow Trend

Aarey Drugs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 41.81
Price to Book 10.15
Price to Sales 0.36
PEG Ratio -1.88

Profitability Ratios

Profit Margin 0.85%
Operating Margin -3.18%
Return on Equity 2.97%
Return on Assets 0.07%

Financial Health

Current Ratio 2.20
Debt to Equity 25.17
Beta 0.40

Per Share Data

EPS (TTM) ₹1.43
Book Value per Share ₹5.89
Revenue per Share ₹168.94

Financial data is updated regularly. All figures are in the company's reporting currency.